Navigation Links
UNC scientists garner new NIH awards for high risk, transformative research
Date:9/23/2009

Three scientists from the University of North Carolina at Chapel Hill School of Medicine and the UNC Lineberger Comprehensive Cancer Center have received prestigious awards from the National Institutes of Health (NIH) aimed at encouraging "high risk" and innovative research.

Klaus Hahn, Ph.D., and Mark Zylka, Ph.D., have received "Transformative" RO1 awards, while Joseph DeSimone, Ph.D., who is also in the UNC College of Arts and Sciences, has been granted a Pioneer Award.

The "Transformative" RO1 awards, new to the NIH this year, are named for the Institutes' standard RO1 grants, but without the traditional budget cap or requirement for preliminary results, and with the flexibility to work in large, complex teams. According to the NIH, this means scientists are free to propose new, bold ideas that may require significant resources to pursue.

The new award program was specifically created under the NIH Roadmap for Medical Research to support exceptionally innovative, high risk, original and/or unconventional research projects that have the potential to create or overturn fundamental paradigms. These projects tend to be inherently risky, but if successful can profoundly impact a broad area of biomedical research.

Hahn, who is the Thurman Professor of Pharmacology in the School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center, is collaborating with Harvard University's Gaudenz Danuser, PhD, to develop new methods of measuring how information flows through large signaling networks within cells.

"Our goal is to build on our laboratory's expertise in biosensor design and live cell imaging, combined with Dr. Danuser's expertise in image analysis of dynamic cellular processes, to design completely new ways to observe the complex signaling process that take place both within living cells and within larger networks of cells," said Hahn.

According to Hahn, current methods for measuring and imaging cell
'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert  

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Scientists outline planetary boundaries: A safe operating space for humanity
2. Ocean observing scientists and marine industries teaming up to sustainably monitor the water column
3. University of Iowa scientists use blood-brain barrier as therapy delivery system
4. Scientists discover key factor in regulating placenta and fetal growth
5. Scientists find that individuals in vegetative states can learn
6. UCLA scientists make paralyzed rats walk again after spinal-cord injury
7. Scientists pinpoint protein link to fat storage
8. Impact of renewable energy on our oceans must be investigated, say scientists
9. UT scientists discover link between protein and lung disease
10. Alert status area in brain discoved by Hebrew University scientists
11. Master gene that switches on disease-fighting cells identified by scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UNC scientists garner new NIH awards for high risk, transformative research
(Date:5/21/2013)... an uphill battle? Try staying fit in space, where ... and bone. , That,s the challenge a group of ... three-year, $1.2 million grant from NASA. Their goal is ... missions. , "You could give astronauts the best exercise ... to stick to it, it isn,t going to help," ...
(Date:5/21/2013)... gathering of biomass experts , Where? ... When? 03-07 June 2013 , ... resource assessment, market and policy developments, manufacturing and installation, ... and benefiting from its 2013 edition from a record ... 60 countries, more than 240 plenary and oral presentations, ...
(Date:5/21/2013)... The epigenetic modifications, which alter the way genes ... apparently be detected in the blood of pregnant ... way to foretell depression in the weeks after ... symptoms become debilitating. , The findings of the ... online in the journal Molecular Psychiatry . ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... times, cells sometimes resort to a form of self-cannibalism ... can have a down side, destroying the pancreas by ... swallows a portion of cytoplasm and ferries it to ... allowing hungry cells to recycle molecules, for example. However, ...
... known to be implicated in Crohn,s disease, a form of ... in the journal Nature Genetics , has identified a ... as providing surprising new links between the condition and other ... 1 in 500 and 1 in 1000 people within the ...
... throughout the world, resulting in large-scale ecosystem alteration and ... drought vary from year to year in severity and ... more severe conditions. Many modern varieties of potatoes ... cultivation in the cold, dry Andean Altiplano gave rise ...
Cached Biology News:Complexity of Crohn's disease revealed as 'gene' count tops 30 2Complexity of Crohn's disease revealed as 'gene' count tops 30 3Drought tolerance in potatoes 2Drought tolerance in potatoes 3
(Date:5/21/2013)... Belmont, MA (PRWEB) May 21, 2013 ... complete tracking to reporting eLearning solution using Tin ... report and dashboard tool. CLD is a leading ... biotech, and medical device companies worldwide. , ... tracking standard that helps learners and trainers more ...
(Date:5/21/2013)... , May 21, 2013 ... Dialysis and Transplant Association) is the biggest congress in ... replacement therapy. Nearly 10,000 participants are in ... the latest research findings. New pioneering studies have been ... "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA ...
(Date:5/21/2013)... New York , May 21, 2013 ... by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products ... Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, ... 2.4 billion in 2011 and is expected to grow ... to reach an estimated value of USD 4.7 billion ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... 12 Two new white papers detailing,sterility ... download from,Microtest ( http://www.microtestlabs.com ). The white ... manufacturers and one which is specialized,for pharmaceutical ... with sterility testing and reviews different testing,methodologies. ...
... Sept. 12 Bionovo, Inc.,(Nasdaq: BNVI ), a pharmaceutical ... drugs in the areas of women,s health and,cancer, announced today ... at A.G. Edwards, 2nd Annual Emerging Growth Conference in New,York. ... ET on Tuesday,September 18, 2007 at the New York Palace ...
... 12 Genstruct Inc., a,biotechnology company translating the ... announced today that its president and,CEO, Dr. Keith ... the Oncology,Clinical Trial Summit in Arlington, Va., September ... panel discussion focused on,"Enhancing Development and Commercial Value ...
Cached Biology Technology:Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2Bionovo to Present at A.G. Edwards' 2nd Annual Emerging Growth Conference 2007 2Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit 2
... Peptide-Protein Conjugation, ... Bridges, Complex Peptides/Peptidomimetics, Special ... Phosphorylated/Biotinylated Structures, Peptide labeling AMC, ... -99%, fitting your needs, Chromogenic/Flurogenic ...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
...
Collected from 8-12 week old sexually mature rats. Pricing: $100/unit for 1 - 10 units...
Biology Products: